Metronidazole vs Rituximab
Metronidazole vs Rituximab: Overview
This comparison examines the pharmacological differences between Metronidazole and Rituximab.
Mechanism of Action
Metronidazole: Forms cytotoxic free radicals that damage bacterial DNA.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Metronidazole β 8 hours; Rituximab β 22 days.
Chemical Properties
Molecular Formula: Metronidazole β C6H9N3O3.
Molecular Weight: Metronidazole β 171.1540 g/mol.
Type: Metronidazole β Small molecule; Rituximab β Antibody.